openPR Logo
Press release

Biopharmaceutical and Biomedicine Market Insights, and Forecast to 2025

08-30-2018 03:08 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Biopharmaceutical and Biomedicine Market Insights,

Biopharmaceuticals has emerged as one of the key segments with immense growth potential in the healthcare sector. Rising demand for effective treatment and rise in per capita healthcare expenditure has led to double digit revenue growth for industry players in the recent past. The industry offers lucrative growth opportunities, since most of these products still have low penetration rate. The market is expected to gain further traction, with evolving treatment archetypes and rapid technological innovation such as cell therapy and regenerative medicines.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/18

Launches and approvals of novel biopharmaceutical and biomedicine products is expected to drastically drive growth of global biopharmaceutical and biomedicine market in the near future. For instance, in 2016, Sanofi S.A. received U.S. FDA approval for its Adlyxin ((lixisenatide) injection. Adlyxin is indicated to improve blood sugar levels among adults suffering from type 2 diabetes. In 2016, Johnson & Johnson received U.S. FDA approval for its Stelara (Ustekinumab), indicated for the treatment of adults suffering from moderately to severely active crohn’s disease. In 2016, CSL Behring received U.S. FDA approval for its IDELVION, Coagulation Factor IX (Recombinant), Albumin Fusion Protein. IDELVION is indicated for the treatment of Hemophilia B among children and adults. In 2017, Nanostring Technologies, Inc. launched nCounter platform advances as well as new panels expanding the company’s presence in immuno-oncology and 3D biology research. In 2015, Celltrion Healthcare Co., Ltd. launched its Remsima (infliximab), a biosimilar monoclonal antibody (mAb) in Austria, Belgium, Denmark, France, Germany, Greece, Italy, Luxembourg, the Netherlands, Spain, Sweden, and the UK.

Furthermore, increasing collaborations and acquisitions by major key players in market is also expected to create lucrative environment for growth of market. For instance, in 2016, Biocon Ltd., wholly owned subsidiary of Biocon SA, collaborated with Laboratorios PiSA S.A. de C.V—a Mexico-based company—for the co-development and commercialization of generic recombinant human insulin (rh-insulin) in the U.S. market. In 2016, AbbVie Inc. acquired all rights from Boehringer Ingelheim (BI) for Risankizumab (BI 655066). Risankizumab is an anti-IL-23 monoclonal biologic antibody for psoriasis. Company is also evaluating the product for other indications such as Crohn’s disease, asthma, and psoriatic arthritis. Currently, it is in clinical phase 3.

Increasing strategic acquisitions and collaboration by key players is expected to drive market growth in the near future

Players in the market are focusing on strategic collaborations, in order to increase their product offerings. In February 2018, LGC Limited— U.K.-based Company acquired Lucigen Corporation, a U.S.-based developer, and manufacturer of molecular biology enzymes, reagents and kits. Through this strategic acquisition, LGC Limited expanded its portfolio with the Lucigen’s extensive portfolio of NGS kits, enzymes, competent cells, and cloning systems. In February 2018, Servier Laboratories and ImmunoQure AG entered into a strategic collaboration for development of a therapeutic autoantibody neutralizing interferon- a. In March 2018, Wuxi Biologics Co. Ltd. collaborated with Adagene Inc., for the discovery and development of novel antibody therapeutics. In 2017, Omicia, Inc., acquired a bioinformatics startup Spiral Genetics at an undisclosed amount. Through this acquisition of Spiral’s advanced tools, Omicia, Inc., expanded its bioinformatics tools portfolio and strengthened its position in the global market.

Moreover, increasing funding and investments to support the development and research of new biopharmaceutical is also expected to drive the market growth. For instance in 2017, Indian government launched a National Biopharmaceutical Mission. As per the program, the government has invested US $250 Mn that includes a US$ 125 Mn loan from the World Bank to promote development of biological drugs in India. In 2017, The University of Liverpool and the Johns Hopkins University School of Medicine (JHUSM) collaborated for the development of new nanomedicine approaches for HIV therapy, and received an award of US$ 3 million from National Institutes of Health (NIH) to generate new technologies and continue research and development.

Cost of biopharmaceutical and biomedicine products are quite high as these need research and development process, and its manufacturing is very complex process, which needs highly skilled scientists. Such expensive biopharmaceutical products are not affordable to organizations in emerging economies such as India, China, and Africa. High cost of biopharmaceutical and biomedicine is a major factor hindering its adoption. For instance, in India a vial of Avastin, a monoclonal antibody, costs between US$ 372.65 to US$ 402.46. High cost medicine is not affordable to everyone, hence, it is a major restraining factor for the market growth. Cost of gene therapy such as Kymriah is very high. Kymriah is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia. The cost of Novartis AG’s cancer therapy Kymriah is about US$ 475,000.

Ask for customization @ https://www.coherentmarketinsights.com/insight/request-customization/18

Key players operating in the global biopharmaceutical and biomedicine market include Amgen Inc., F. Hoffmann-La Roche AG, Novartis AG, Johnson & Johnson, Pfizer, Inc., Sanofi S.A., Eli Lilly and Company, AbbVie Inc., Novo Nordisk A/S, Bristol - Myers Squibb, NanoString Technologies, Inc., Qiagen N.V., Celgene Corporation, and Affimed N.V.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopharmaceutical and Biomedicine Market Insights, and Forecast to 2025 here

News-ID: 1212626 • Views: 444

More Releases from Coherent Market Insights

Insulin Pumps Market Analysis With Global Business Opportunities Assessment With …
Key Industry Trends of Global Insulin Pumps Market: The growing digitalization, along with the expanding education industry across the globe, represents one of the key factors stimulating the market growth. Additionally, there is an increase in the adoption of smartphones, desktops, and tablets around the world. This, along with technological advancements like the integration of artificial intelligence (AI), virtual reality (VR) and cloud-computing solutions, is another growth-inducing factor. Furthermore, extensive investments
Self-testing Market Infrastructure Growth and Development 2022 to 2028 | Abbott, …
𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐢𝐬 𝐚 𝐜𝐫𝐮𝐜𝐢𝐚𝐥 𝐬𝐭𝐞𝐩 𝐢𝐧 𝐭𝐡𝐞 𝐜𝐮𝐫𝐫𝐞𝐧𝐭 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐩𝐚𝐜𝐞 𝐭𝐡𝐚𝐭 𝐡𝐞𝐥𝐩𝐬 𝐢𝐝𝐞𝐧𝐭𝐢𝐟𝐲 𝐭𝐡𝐞 𝐫𝐢𝐠𝐡𝐭 𝐭𝐚𝐫𝐠𝐞𝐭 𝐜𝐮𝐬𝐭𝐨𝐦𝐞𝐫𝐬 𝐚𝐧𝐝 𝐚𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠𝐥𝐲 𝐩𝐫𝐨𝐯𝐢𝐝𝐞 𝐭𝐚𝐢𝐥𝐨𝐫𝐞𝐝 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞𝐢𝐫 𝐛𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐧𝐞𝐞𝐝𝐬. 𝐄𝐯𝐞𝐫𝐲 𝐚𝐬𝐩𝐞𝐜𝐭 𝐚𝐧𝐝 𝐮𝐧𝐢𝐪𝐮𝐞 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐩𝐮𝐭 𝐮𝐩 𝐛𝐲 𝐭𝐡𝐞 𝐩𝐚𝐫𝐭𝐢𝐜𝐮𝐥𝐚𝐫 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐚𝐫𝐞 𝐜𝐚𝐫𝐞𝐟𝐮𝐥𝐥𝐲 𝐭𝐚𝐤𝐞𝐧 𝐢𝐧𝐭𝐨 𝐜𝐨𝐧𝐬𝐢𝐝𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐰𝐡𝐢𝐥𝐞 𝐟𝐨𝐫𝐦𝐮𝐥𝐚𝐭𝐢𝐧𝐠 𝐭𝐡𝐞𝐬𝐞 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬. 𝐈𝐭 𝐚𝐥𝐬𝐨 𝐭𝐚𝐤𝐞𝐬 𝐢𝐧𝐭𝐨 𝐜𝐨𝐧𝐬𝐢𝐝𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐯𝐚𝐫𝐢𝐨𝐮𝐬 𝐠𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭 𝐫𝐞𝐟𝐨𝐫𝐦𝐬, 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐞𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭, 𝐜𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐛𝐞𝐡𝐚𝐯𝐢𝐨𝐫, 𝐞𝐱𝐢𝐬𝐭𝐢𝐧𝐠 𝐚𝐧𝐝 𝐮𝐩𝐜𝐨𝐦𝐢𝐧𝐠 𝐛𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐦𝐨𝐝𝐞𝐥𝐬, 𝐚𝐧𝐝 𝐞𝐯𝐞𝐫-𝐞𝐯𝐨𝐥𝐯𝐢𝐧𝐠 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬. 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲
Ambulatory Blood Pressure Monitors Market 2022 In Consumer Goods Segment, Demand …
Key Industry Trends of Global Ambulatory Blood Pressure Monitors Market: The growing digitalization, along with the expanding education industry across the globe, represents one of the key factors stimulating the market growth. Additionally, there is an increase in the adoption of smartphones, desktops, and tablets around the world. This, along with technological advancements like the integration of artificial intelligence (AI), virtual reality (VR) and cloud-computing solutions, is another growth-inducing factor. Furthermore,
Lyophilized Product Market Is Booming Across the Globe Explored in Latest Resear …
𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐢𝐬 𝐚 𝐜𝐫𝐮𝐜𝐢𝐚𝐥 𝐬𝐭𝐞𝐩 𝐢𝐧 𝐭𝐡𝐞 𝐜𝐮𝐫𝐫𝐞𝐧𝐭 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐩𝐚𝐜𝐞 𝐭𝐡𝐚𝐭 𝐡𝐞𝐥𝐩𝐬 𝐢𝐝𝐞𝐧𝐭𝐢𝐟𝐲 𝐭𝐡𝐞 𝐫𝐢𝐠𝐡𝐭 𝐭𝐚𝐫𝐠𝐞𝐭 𝐜𝐮𝐬𝐭𝐨𝐦𝐞𝐫𝐬 𝐚𝐧𝐝 𝐚𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠𝐥𝐲 𝐩𝐫𝐨𝐯𝐢𝐝𝐞 𝐭𝐚𝐢𝐥𝐨𝐫𝐞𝐝 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞𝐢𝐫 𝐛𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐧𝐞𝐞𝐝𝐬. 𝐄𝐯𝐞𝐫𝐲 𝐚𝐬𝐩𝐞𝐜𝐭 𝐚𝐧𝐝 𝐮𝐧𝐢𝐪𝐮𝐞 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐩𝐮𝐭 𝐮𝐩 𝐛𝐲 𝐭𝐡𝐞 𝐩𝐚𝐫𝐭𝐢𝐜𝐮𝐥𝐚𝐫 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐚𝐫𝐞 𝐜𝐚𝐫𝐞𝐟𝐮𝐥𝐥𝐲 𝐭𝐚𝐤𝐞𝐧 𝐢𝐧𝐭𝐨 𝐜𝐨𝐧𝐬𝐢𝐝𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐰𝐡𝐢𝐥𝐞 𝐟𝐨𝐫𝐦𝐮𝐥𝐚𝐭𝐢𝐧𝐠 𝐭𝐡𝐞𝐬𝐞 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬. 𝐈𝐭 𝐚𝐥𝐬𝐨 𝐭𝐚𝐤𝐞𝐬 𝐢𝐧𝐭𝐨 𝐜𝐨𝐧𝐬𝐢𝐝𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐯𝐚𝐫𝐢𝐨𝐮𝐬 𝐠𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭 𝐫𝐞𝐟𝐨𝐫𝐦𝐬, 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐞𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭, 𝐜𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐛𝐞𝐡𝐚𝐯𝐢𝐨𝐫, 𝐞𝐱𝐢𝐬𝐭𝐢𝐧𝐠 𝐚𝐧𝐝 𝐮𝐩𝐜𝐨𝐦𝐢𝐧𝐠 𝐛𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐦𝐨𝐝𝐞𝐥𝐬, 𝐚𝐧𝐝 𝐞𝐯𝐞𝐫-𝐞𝐯𝐨𝐥𝐯𝐢𝐧𝐠 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬. 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲

All 5 Releases


More Releases for Biopharmaceutical

Biopharmaceutical Market - Massive Growth opportunity Ahead
A new research document with title 'State of the Biopharmaceutical Industry 2021' covering detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions and important players/vendors. The report will help user gain market insights, future trends and growth prospects for forecast period of 2021 Get customization & check discount for report @ https://www.htfmarketreport.com/request-discount/3060794-state-of-the-biopharmaceutical-industry Summary 2021 promises to be a year of continued innovation and change in the
Biopharmaceutical Logistics Market Is Thriving Worldwide |
The Biopharmaceutical Logistics Market Research Report aims to provide insights that strongly demonstrate the market structure, scope, history, potential, and development perspective. By crossing through the historical and present market status, the Biopharmaceutical Logistics market report provides authentic and reliable estimates for the forecast period. It became essential to distinguish the saturation of consumption in the Biopharmaceutical Logistics market owing to building competitiveness. Hence, the report furnishes a deep-felt market segmentation
Biopharmaceutical Drug Delivery Technologies Market Size, Share, Development by …
New report published by Global Info Research which offers insights on the Global Biopharmaceutical Drug Delivery Technologies market. Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-biopharmaceutical-drug-delivery-technologies-market_p103529.html Global Biopharmaceutical Drug Delivery Technologies Market: Forecast by Type / Application / Region This report studies the Biopharmaceutical Drug Delivery Technologies market status and
Biopharmaceutical Contract Manufacturing (BCMO) Market 2018 – 2024 | PBIGP
A Study On Biopharmaceutical Contract Manufacturing (BCMO) Market: Biopharmaceutical products are pharmaceutical drugs that are synthesized, processed, or extracted from biological sources. Biopharmaceuticals include vaccines, blood products, recombinant therapeutic proteins, allergens, gene therapies, tissues and living cells used in cell therapy. Due to lack of manufacturing capabilities and to reduce the cost of manufacturing process, many companies are outsourcing. Contract manufacturing organizations offer a wide range of services such as
Influx of Technologically Advanced Biopharmaceutical and Biomedicine Drives the …
Biopharmaceuticals has emerged as one of the key segments with immense growth potential in the healthcare sector. Rising demand for effective treatment and rise in per capita healthcare expenditure has led to double digit revenue growth for industry players in the recent past. The industry offers lucrative growth opportunities, since most of these products still have low penetration rate. The market is expected to gain further traction, with evolving treatment
Global Biopharmaceutical Contract Manufacturing Market 2025
Press Release - 16 July 2018 Research and Development News -- . . Latest Update "Global Biopharmaceutical Contract Manufacturing Market Size,Status and Forecast 2025" with Industries Survey | Global Current Growth and Future. ' ' This report studies the global Biopharmaceutical Contract Manufacturing market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Biopharmaceutical Contract Manufacturing market by companies, region, type and end-use industry. A contract manufacturer ("CM")